(Stroke. 2002;33:1685.)
© 2002 American Heart Association, Inc.
Original Contributions |
From the Department of Pharmacology, College of Medicine, University of California at Irvine (A.M.M., S.P.D., D.N.K.), and Department of Obstetrics and Gynecology, Womens and Childrens Hospital, University of Southern California, Los Angeles (C.Z., F.Z.S.).
Reprint requests to Sue P. Duckles, PhD, Department of Pharmacology, College of Medicine, University of California at Irvine, Irvine, CA 92697-4625. E-mail spduckle{at}uci.edu
Background and Purpose In vivo and in vitro rat models of hormone therapy were used to test the following hypotheses: (1) estrogen acts directly on cerebrovascular estrogen receptors to increase endothelial nitric oxide synthase (eNOS); (2) increased protein correlates with higher NOS activity; and (3) effects of estrogen on eNOS are altered by concurrent treatment with either medroxyprogesterone acetate (MPA) or progesterone.
Methods Blood vessels were isolated from brains of ovariectomized female rats; some were treated for 1 month with estrogen, estrogen and progesterone, or estrogen and MPA. Isolated cerebral vessels were also treated in vitro with estrogen in the absence and presence of progesterone, MPA, tamoxifen, and the estrogen receptor antagonist ICI 182 780. Levels of eNOS were measured by Western blot, and NOS activity was measured by [14C]arginine-[14C]citrulline conversion.
Results Chronic hormone treatment in vivo resulted in plasma levels of 17ß-estradiol, progesterone, and MPA in the range of values found in humans. Estrogen treatment resulted in higher levels of cerebrovascular NOS activity that paralleled increases in eNOS protein. In vitro estrogen treatment for 18 hours also resulted in a concentration-dependent increase in eNOS protein (EC50
300 pmol/L) that was completely prevented by estrogen receptor antagonists tamoxifen or ICI 182 780. However, cotreatment with progesterone or MPA, either in vivo or in vitro, did not alter the effect of estrogen on eNOS protein.
Conclusions Estrogen receptor activation in cerebrovascular tissue results in increased eNOS activity and protein levels. The latter effect persists in the presence of either progesterone or MPA. Thus, increased NO production by eNOS may contribute to the neuroprotective effects of estrogen.
Key Words: cerebral vessels estrogens nitric oxide synthase rats
This article has been cited by other articles:
![]() |
X.-D. Fu, M. Flamini, A. M. Sanchez, L. Goglia, M. S. Giretti, A. R. Genazzani, and T. Simoncini Progestogens regulate endothelial actin cytoskeleton and cell movement via the actin-binding protein moesin Mol. Hum. Reprod., April 1, 2008; 14(4): 225 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Nevo, J. F. Soustiel, and I. Thaler Cerebral blood flow is increased during controlled ovarian stimulation Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3265 - H3269. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Begg, S. Kent, M. J. McKinley, and M. L. Mathai Suppression of endotoxin-induced fever in near-term pregnant rats is mediated by brain nitric oxide Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2007; 292(6): R2174 - R2178. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Monsalve, P. J. Oviedo, M. A. Garcia-Perez, J. J. Tarin, A. Cano, and C. Hermenegildo Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells Cardiovasc Res, January 1, 2007; 73(1): 66 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Krause, S. P. Duckles, and D. A. Pelligrino Influence of sex steroid hormones on cerebrovascular function J Appl Physiol, October 1, 2006; 101(4): 1252 - 1261. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sunday, M. M. Tran, D. N. Krause, and S. P. Duckles Estrogen and progestagens differentially modulate vascular proinflammatory factors Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E261 - E267. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Garthwaite, K. Bartus, D. Malcolm, D. Goodwin, M. Kollb-Sielecka, C. Dooldeniya, and J. Garthwaite Signaling from blood vessels to CNS axons through nitric oxide. J. Neurosci., July 19, 2006; 26(29): 7730 - 7740. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stirone, S. P. Duckles, D. N. Krause, and V. Procaccio Estrogen Increases Mitochondrial Efficiency and Reduces Oxidative Stress in Cerebral Blood Vessels Mol. Pharmacol., October 1, 2005; 68(4): 959 - 965. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gingerich and T. L. Krukoff Estrogen Modulates Endothelial and Neuronal Nitric Oxide Synthase Expression via an Estrogen Receptor {beta}-Dependent Mechanism in Hypothalamic Slice Cultures Endocrinology, July 1, 2005; 146(7): 2933 - 2941. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stirone, A. Boroujerdi, S. P. Duckles, and D. N. Krause Estrogen Receptor Activation of Phosphoinositide-3 Kinase, Akt, and Nitric Oxide Signaling in Cerebral Blood Vessels: Rapid and Long-Term Effects Mol. Pharmacol., January 1, 2005; 67(1): 105 - 113. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Simoncini, P. Mannella, L. Fornari, A. Caruso, M. Y. Willis, S. Garibaldi, C. Baldacci, and A. R. Genazzani Differential Signal Transduction of Progesterone and Medroxyprogesterone Acetate in Human Endothelial Cells Endocrinology, December 1, 2004; 145(12): 5745 - 5756. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xia and T. L. Krukoff Estrogen Induces Nitric Oxide Production via Activation of Constitutive Nitric Oxide Synthases in Human Neuroblastoma Cells Endocrinology, October 1, 2004; 145(10): 4550 - 4557. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, G. G. Geary, R. J. Gonzales, D. N. Krause, and S. P. Duckles Effect of estrogen on cerebrovascular prostaglandins is amplified in mice with dysfunctional NOS Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H588 - H594. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Sobey, J. M. Weiler, M. Boujaoude, and O. L. Woodman Effect of Short-Term Phytoestrogen Treatment in Male Rats on Nitric Oxide-Mediated Responses of Carotid and Cerebral Arteries: Comparison with 17{beta}-Estradiol J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 135 - 140. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ospina, H. N. Brevig, D. N. Krause, and S. P. Duckles Estrogen suppresses IL-1{beta}-mediated induction of COX-2 pathway in rat cerebral blood vessels Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H2010 - H2019. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ospina, S. P. Duckles, and D. N. Krause 17{beta}-Estradiol decreases vascular tone in cerebral arteries by shifting COX-dependent vasoconstriction to vasodilation Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H241 - H250. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. McKee, D. A. Van Riper, C. A. Davison, and H. A. Singer Gender-dependent modulation of alpha 1-adrenergic responses in rat mesenteric arteries Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1737 - H1743. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stirone, S. P. Duckles, and D. N. Krause Multiple forms of estrogen receptor-alpha in cerebral blood vessels: regulation by estrogen Am J Physiol Endocrinol Metab, January 1, 2003; 284(1): E184 - E192. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |